Research Reporting Standards for Percutaneous Thermal Ablation of Lung Neoplasms

Received 8 December 2008; received in revised form 5 January 2009; accepted 5 January 2009. published online 26 February 2009.

Abbreviations: FGD, [18F]fluorodeoxyglucose, NSCLC, non–small-cell lung cancer, PET, positron emission tomography, RF, radiofrequency, SIRTAC/IWGIGTA, Society of Interventional Radiology Technology Assessment Committee and International Working Group on Image-Guided Tumor Ablation

No abstract is available. To read the body of this article, please view the Full Text online.

a Section of Interventional Oncology, Department of Radiology, University of California San Diego Medical Center, San Diego, California

b Department of Diagnostic Imaging, Brown Medical School, Rhode Island Hospital, Providence, Rhode Island

c Gastrointestinal/Genitourinary Division, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts

d Department of Radiology, University of Western Ontario, London

e Department of Radiology, Peterborough Regional Health Centre, Peterborough, Ontario, Canada

f Division of Interventional Radiology, Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

g Department of Radiology, Geisinger Health System, Danville, Pennsylvania

h Department of Interventional Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Address correspondence to S.C.R., c/o Tricia McClenny, Society of Interventional Radiology, 3975 Fair Ridge Dr., Suite 400 N., Fairfax, VA 22033

S.C.R. is a stockholder in Boston Scientific (Natick, Massachusetts). D.E.D. has received grant support from Endocare (Irvine, California), Veran Medical (St. Louis, Missouri), Angiodynamics (Queensbury, New York), Biotex (Houston, Texas), PneumRx (Mountain View, California), and Medwaves (San Diego, California); serves as a consultant for Ethicon (Somerville, New Jersey), BSD Medical (Salt Lake City, Utah), and Medwaves (San Diego, California); and has received honoraria from Covidien (Mansfield, Massachusetts). D.A.G. has received research funding and serves as a speaker for Covidien (Mansfield, Massachusetts). M.J.W. has received honoraria and research funding from Siemens Medical Solutions (Erlangen, Germany). None of the other authors have identified a conflict of interest.

PII: S1051-0443(09)00018-9

doi:10.1016/j.jvir.2009.01.016

43 of 51